Haloperidol Decanoate NDC 70756-625

Product information

Brand name (proprietary)

Haloperidol Decanoate

Generic name (nonproprietary)

haloperidol decanoate

Active ingredients

Haloperidol decanoate — 500 mg/5mL

Dosage form

Injection

Route

Intramuscular

Labeler

Lifestar Pharma LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 216730

Marketing start

May 23, 2023

Listing expires

Dec 31, 2027

Identifiers

Product ID 70756-625_b6a0b666-3e71-45a5-841e-af674068c7aaSPL ID b6a0b666-3e71-45a5-841e-af674068c7aaSPL set ID 8a96195e-97cd-4161-96e0-494a1636fa9cRxCUI 859867, 859871, 1719803, 1719862UNII AC20PJ4101UPC 0370756615811, 0370756624851, 0370756616818, 0370756625858

Pharmacologic class

Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470756062505 followed by a unit qualifier and the quantity Copy

Package 70756-0625-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 216730

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.